Author： Ku Geoffrey Y Ilson David H
Publisher： Informa Healthcare
ISSN： 1472-8214
Source： Expert Opinion on Emerging Drugs, Vol.18, Iss.2, 2013-06, pp. : 219-230
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Protein tyrosine kinase inhibitors in cancer treatment
By Traxler P.M.
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 6, 1997-06 ,pp. :
Tyrosine kinase inhibitors in cancer treatment (Part II)
By Traxler P.
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. :
Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer
Current Drug Targets, Vol. 10, Iss. 6, 2009-06 ,pp. :
Selective tyrosine kinase inhibitors
Expert Opinion on Emerging Drugs, Vol. 5, Iss. 3, 2000-10 ,pp. :